Back

MLIP and Junctophilin-1 exhibit atypical phosphosites in diabetic hearts: a novel therapeutic target for diabetic cardiomyopathy?

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Basic science - cardiac disease 3 Cardiomyopathies HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Stephanie Chacar

Khalifa University, Abu Dhabi (United Arab Emirates)

6 More presentations in this session

Presentation thumbnail
Reversal of age-related diastolic dysfunction in rats by procyanidins and oenothein B with suppression of NOS-NO/ROS imbalance and reduced left ventricular remodeling and fibrosis
Ms H. MUZAMMEL (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Tenascin-C inhibition rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes
Ms J. Marksteiner (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
High-throughput proteomic analysis unveils metabolic and mitochondrial signaling rewiring by chronic ivabradine treatment in duchenne muscular dystrophy
Mr C. Dostal (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Computational models of cardiac metabolism reveal distinct metabolic phenotypes in dilated cardiomyopathy patients
Mr B. Nihant (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
The impact of the endocannabinoid system on the profibrotic profile of cardiac fibroblasts associated with DMD
Doctor L. Savchenko (Toulouse, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science - cardiac disease 3

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
thumbnail
Congress Presentation
Signature of diabetic cardiomyopathy progression using high-fat diet and streptozotocin mouse model: from subclinical to clinical with three-hit mouse model
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor dapagliflozin on myocardial protein profile in rats with long-standing Type 1 diabetes mellitus

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources